Cargando…
Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
PURPOSE: To describe the treatment outcomes and recurrence risk of chronic central serous chorioretinopathy (cCSC) in patients who had complete resolution of subretinal fluid (SRF) after either primary half‐dose photodynamic therapy (PDT) or high‐density subthreshold micropulse laser (HSML) in the P...
Autores principales: | van Rijssen, Thomas J., van Dijk, Elon H. C., Scholz, Paula, Breukink, Myrte B., Dijkman, Greet, Peters, Petrus J. H., Tsonaka, Roula, Keunen, Jan E. E., MacLaren, Robert E., Hoyng, Carel B., Downes, Susan M., Fauser, Sascha, Boon, Camiel J. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596593/ https://www.ncbi.nlm.nih.gov/pubmed/33565230 http://dx.doi.org/10.1111/aos.14775 |
Ejemplares similares
-
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
por: Breukink, Myrte B., et al.
Publicado: (2015) -
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020) -
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati, Danial, et al.
Publicado: (2018) -
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
por: Breukink, Myrte B, et al.
Publicado: (2016) -
Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)